| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Stapleton Craig R is a Director at AVADEL PHARMACEUTICALS PLC with holdings across 2 companies. Recent SEC Form 4 filings include 14 buys and 1 sell.
Estimated insider holdings value: $5.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 27, 2017 | AVDL Avadel Pharmaceuticals Plc | Director | Sell | 254,265 | $9.35 | $2,377,632.02 | -50.1% | |
| Sep 12, 2017 | AVDL Avadel Pharmaceuticals Plc | Director | Buy | 20,000 | $9.52 | $190,360.00 | +22.2% | |
| May 22, 2017 | AVDL Avadel Pharmaceuticals Plc | Director | Buy | 31,013 | $9.85 | $305,326.74 | +15.3% | |
| Nov 29, 2016 | AVDL Avadel Pharmaceuticals Plc | Director | Buy | 20,000 | $10.79 | $215,870.00 | +40.0% | |
| Sep 1, 2016 | AVDL Avadel Pharmaceuticals Plc | Director | Buy | 10,000 | $13.52 | $135,190.00 | +2.0% | |
| Sep 1, 2016 | ANF Abercrombie & Fitch Co /de/ | Director | Buy | 10,000 | $17.65 | $176,500.00 | +21.1% | |
| Aug 26, 2016 | AVDL Avadel Pharmaceuticals Plc | Director | Buy | 20,000 | $13.76 | $275,140.48 | +183.9% | |
| May 16, 2016 | AVDL Avadel Pharmaceuticals Plc | Director | Buy | 27,228 | $9.21 | $250,891.29 | +2.8% | |
| Mar 14, 2016 | AVDL Avadel Pharmaceuticals Plc | Director | Buy | 100,000 | $10.39 | $1,039,400.00 | +26.1% | |
| Jun 22, 2015 | ANF Abercrombie & Fitch Co /de/ | Director | Buy | 10,000 | $22.42 | $224,200.00 | +26.7% |